Achalasia

Gastroenterology Clinics of North America

Volumn 37, Issue 4, 2008, Pages 807-825

  Walzer, Natasha ^a   Hirano, Ikuo ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Achalasia; Dysphagia; Esophageal motility; Esophageal motility disorder; Esophagus; Lower esophageal sphincter

Indexed keywords

ANTIBIOTIC AGENT; AUTOANTIBODY; BOTULINUM TOXIN; CALCIUM CHANNEL BLOCKING AGENT; HLA DQ ANTIGEN; NIFEDIPINE; NITRIC ACID DERIVATIVE; NITRIC OXIDE; PLACEBO; PROTON PUMP INHIBITOR; SILDENAFIL;

AUTOIMMUNITY; BARRETT ESOPHAGUS; CANCER RISK; CARDIOESOPHAGOMYOTOMY; CHAGAS DISEASE; CLINICAL TRIAL; COST EFFECTIVENESS ANALYSIS; DOSAGE SCHEDULE COMPARISON; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG MECHANISM; DYSPHAGIA; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGOGRAPHY; ESOPHAGUS ACHALASIA; ESOPHAGUS CANCER; ESOPHAGUS DILATATION; ESOPHAGUS INJURY; ESOPHAGUS MANOMETRY; ESOPHAGUS MOTILITY; ESOPHAGUS PAIN; ESOPHAGUS PERFORATION; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL HEMORRHAGE; GENETIC SUSCEPTIBILITY; HEARTBURN; HEMATOMA; HUMAN; HYPOTENSION; INTERMETHOD COMPARISON; PATHOGENESIS; PATHOPHYSIOLOGY; PATIENT SAFETY; PERIPHERAL EDEMA; PNEUMATIC TOOL; REPEATED DRUG DOSE; REVIEW; SIDE EFFECT; SINGLE DRUG DOSE; SQUAMOUS CELL CARCINOMA; THORAX PAIN; TREATMENT OUTCOME; TREATMENT RESPONSE; VARICELLA ZOSTER VIRUS; VASODILATATION; WEIGHT REDUCTION;

ESOPHAGEAL ACHALASIA; HUMANS;

EID: 56349153626     PISSN: 08898553     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.gtc.2008.09.002     Document Type: Review

References (75)

1. Mayberry J.F. Epidemiology and demographics of achalasia. Gastrointest Endosc Clin N Am 11 (2001) 235-248
2. Blam M.E., Delfyett W., Levine M.S., et al. Achalasia: a disease of varied and subtle symptoms that do not correlate with radiographic findings. Am J Gastroenterol 97 (2002) 1916-1923
3. Eckardt V.F., Stauf B., and Bernhard G. Chest pain in achalasia: patient characteristics and clinical course. Gastroenterology 116 (1999) 1300-1304
4. Perretta S., Fisichella P.M., Galvani C., et al. Achalasia and chest pain: effect of laparoscopic Heller myotomy. J Gastrointest Surg 7 (2003) 595-598
5. Spechler S.J., Souza R.F., Rosenberg S.J., et al. Heartburn in patients with achalasia. Gut 37 (1995) 305-308
6. Shoenut J.P., Micflikier A.B., Yaffe C.S., et al. Reflux in untreated achalasia patients. J Clin Gastroenterol 20 (1995) 6-11
7. Howard P.J., Maher L., Pryde A., et al. Five year prospective study of the incidence, clinical features, and diagnosis of achalasia in Edinburgh. Gut 33 (1992) 1011-1015
8. Pandolfino JP, Kwiatek MA, Nealis, T, et al. Achalasia: a new clinically relevant classification by high resolution manometry. Gastroenterology, in press.
9. Nguyen H.N., Domingues G.R., Winograd R., et al. Impedance characteristics of esophageal motor function in achalasia. Dis Esophagus 17 (2004) 44-50
10. Conchillo J.M., Selimah M., Bredenoord A.J., et al. Assessment of oesophageal emptying in achalasia patients by intraluminal impedance monitoring. Neurogastroenterol Motil 18 (2006) 971-977
11. Goldblum J.R., Rice T.W., and Richter J.E. Histopathologic features in esophagomyotomy specimens from patients with achalasia. Gastroenterology 111 (1996) 648-654
12. Camacho-Lobato L., Katz P.O., Eveland J., et al. Vigorous achalasia: original description requires minor change. J Clin Gastroenterol 33 (2001) 375-377
13. Pasricha P.J., Rai R., Ravich W.J., et al. Botulinum toxin for achalasia: long-term outcome and predictors of response. Gastroenterology 110 (1996) 1410-1415
14. Hirano I., Tatum R.P., Shi G., et al. Manometric heterogeneity in patients with idiopathic achalasia. Gastroenterology 120 (2001) 789-798
15. de Oliveira R.B., Troncon L.E., Dantas R.O., et al. Gastrointestinal manifestations of Chagas' disease. Am J Gastroenterol 93 (1998) 884-889
16. Holloway R.H., Dodds W.J., Helm J.F., et al. Integrity of cholinergic innervation to the lower esophageal sphincter in achalasia. Gastroenterology 90 (1986) 924-929
17. Dodds W.J., Dent J., Hogan W.J., et al. Paradoxical lower esophageal sphincter contraction induced by cholecystokinin-octapeptide in patients with achalasia. Gastroenterology 80 (1981) 327-333
18. Tottrup A., Ny L., Alm P., et al. The role of the l-arginine/nitric oxide pathway for relaxation of the human lower oesophageal sphincter. Acta Physiol Scand 149 (1993) 451-459
19. Robertson C.S., Martin B.A., and Atkinson M. Varicella-zoster virus DNA in the oesophageal myenteric plexus in achalasia. Gut 34 (1993) 299-302
20. Facco M., Brun P., Baesso I., et al. T cells in the myenteric plexus of achalasia patients show a skewed TCR repertoire and react to HSV-1 antigens. Am J Gastroenterol 103 (2008) 1598-1609
21. Moses P.L., Ellis L.M., Anees M.R., et al. Antineuronal antibodies in idiopathic achalasia and gastro-oesophageal reflux disease. Gut 52 (2003) 629-636
22. Raymond L., Lach B., and Shamji F.M. Inflammatory aetiology of primary oesophageal achalasia: an immunohistochemical and ultrastructural study of Auerbach's plexus. Histopathology 35 (1999) 445-453
23. Clark S.B., Rice T.W., Tubbs R.R., et al. The nature of the myenteric infiltrate in achalasia: an immunohistochemical analysis. Am J Surg Pathol 24 (2000) 1153-1158
24. Wong R.K., Maydonovitch C.L., Metz S.J., et al. Significant DQw1 association in achalasia. Dig Dis Sci 34 (1989) 349-352
25. Ruiz-de-Leon A., Mendoza J., Sevilla-Mantilla C., et al. Myenteric antiplexus antibodies and class II HLA in achalasia. Dig Dis Sci 47 (2002) 15-19
26. Vaezi M.F., Baker M.E., and Richter J.E. Assessment of esophageal emptying post-pneumatic dilation: use of the timed barium esophagram. Am J Gastroenterol 94 (1999) 1802-1807
27. Eckardt V.F., Aignherr C., and Bernhard G. Predictors of outcome in patients with achalasia treated by pneumatic dilation. Gastroenterology 103 (1992) 1732-1738
28. Montazeri G., Nouri N., Estakhri A., et al. Surface area: a better predictor of disease severity than the height and volume of the barium column in patients with primary achalasia. Eur J Gastroenterol Hepatol 18 (2006) 1203-1208
29. Vaezi M.F., Richter J.E., Wilcox C.M., et al. Botulinum toxin versus pneumatic dilatation in the treatment of achalasia: a randomised trial. Gut 44 (1999) 231-239
30. Pasricha P.J., Ravich W.J., Hendrix T.R., et al. Intrasphincteric botulinum toxin for the treatment of achalasia. N Engl J Med 332 (1995) 774-778
31. Wen Z.H., Gardener E., and Wang Y.P. Nitrates for achalasia. Cochrane Database Syst Rev (2004) CD002299
32. Bortolotti M., Mari C., Lopilato C., et al. Effects of sildenafil on esophageal motility of patients with idiopathic achalasia. Gastroenterology 118 (2000) 253-257
33. Annese V., Bassotti G., Coccia G., et al. A multicentre randomised study of intrasphincteric botulinum toxin in patients with oesophageal achalasia: GISMAD Achalasia Study Group. Gut 46 5 (2000) 597-600
34. Horgan S., Hda K., Eubanks T., et al. Does botulinum toxin injection make esophagomyotomy a more difficult operation?. Surg Endosc 13 (1999) 576-579
35. Patti M.G., Feo C.V., Arcerito M., et al. Effects of previous treatment on results of laparoscopic Heller myotomy for achalasia. Dig Dis Sci 44 (1999) 2270-2276
36. Cowgill S.M., Villadolid D.V., Al-Saadi S., et al. Difficult myotomy is not determined by preoperative therapy and does not impact outcome. JSLS 11 (2007) 336-343
37. Kadakia S.C., and Wong R.K. Graded pneumatic dilation using Rigiflex achalasia dilators in patients with primary esophageal achalasia. Am J Gastroenterol 88 (1993) 34-38
38. Torbey C.F., Achkar E., Rice T.W., et al. Long-term outcome of achalasia treatment: the need for closer follow-up. J Clin Gastroenterol 28 (1999) 125-130
39. West R.L., Hirsch D.P., Bartelsman J.F., et al. Long-term results of pneumatic dilation in achalasia followed for more than 5 years. Am J Gastroenterol 97 (2002) 1346-1351
40. Ghoshal U.C., Kumar S., Saraswat V.A., et al. Long-term follow-up after pneumatic dilation for achalasia cardia: factors associated with treatment failure and recurrence. Am J Gastroenterol 99 (2004) 2304-2310
41. Karamanolis G., Sgouros S., Karatzias G., et al. Long-term outcome of pneumatic dilation in the treatment of achalasia. Am J Gastroenterol 100 (2005) 270-274
42. Zerbib F., Thetiot V., Richy F., et al. Repeated pneumatic dilations as long-term maintenance therapy for esophageal achalasia. Am J Gastroenterol 101 (2006) 692-697
43. Vaezi M.F., Baker M.E., Achkar E., et al. Timed barium oesophagram: better predictor of long-term success after pneumatic dilation in achalasia than symptom assessment. Gut 50 (2002) 765-770
44. Vela M.F., Richter J.E., Wachsberger D., et al. Complexities of managing achalasia at a tertiary referral center: use of pneumatic dilatation, Heller myotomy, and botulinum toxin injection. Am J Gastroenterol 99 (2004) 1029-1036
45. Metman E.H., Lagasse J.P., d'Alteroche L., et al. Risk factors for immediate complications after progressive pneumatic dilation for achalasia. Am J Gastroenterol 94 (1999) 1179-1185
46. Schwartz H.M., Cahow C.E., and Traube M. Outcome after perforation sustained during pneumatic dilatation for achalasia. Dig Dis Sci 38 (1993) 1409-1413
47. Molina E.G., Stollman N., Grauer L., et al. Conservative management of esophageal nontransmural tears after pneumatic dilation for achalasia. Am J Gastroenterol 91 (1996) 15-18
48. Shoenut J.P., Duerksen D., and Yaffe C.S. A prospective assessment of gastroesophageal reflux before and after treatment of achalasia patients: pneumatic dilation versus transthoracic limited myotomy. Am J Gastroenterol 92 (1997) 1109-1112
49. Burke C.A., Achkar E., and Falk G.W. Effect of pneumatic dilation on gastroesophageal reflux in achalasia. Dig Dis Sci 42 (1997) 998-1002
50. Patti M.G., Pellegrini C.A., Horgan S., et al. Minimally invasive surgery for achalasia: an 8-year experience with 168 patients. Ann Surg 230 (1999) 587-593 [discussion: 593-4]
51. Zhu Z.J., Chen L.Q., and Duranceau A. Long-term result of total versus partial fundoplication after esophagomyotomy for primary esophageal motor disorders. World J Surg 32 (2008) 401-407
52. Oelschlager B.K., Chang L., and Pellegrini C.A. Improved outcome after extended gastric myotomy for achalasia. Arch Surg 138 (2003) 490-495 [discussion: 495-7]
53. Wright A.S., Williams C.W., Pellegrini C.A., et al. Long-term outcomes confirm the superior efficacy of extended Heller myotomy with Toupet fundoplication for achalasia. Surg Endosc 21 (2007) 713-718
54. Tsiaoussis J., Pechlivanides G., Gouvas N., et al. Patterns of esophageal acid exposure after laparoscopic Heller's myotomy and Dor's fundoplication for esophageal achalasia. Surg Endosc 22 (2007) 1493-1499
55. Sharp K.W., Khaitan L., Scholz S., et al. 100 Consecutive minimally invasive Heller myotomies: lessons learned. Ann Surg 235 (2002) 631-638 [discussion: 638-9]
56. Raiser F., Perdikis G., Hinder R.A., et al. Heller myotomy via minimal access surgery: an evaluation of antireflux procedures. Arch Surg 131 (1996) 593-597 [discussion: 597-8]
57. Tatum R.P., Kahrilas P.J., Manka M., et al. Operative manometry and endoscopy during laparoscopic Heller myotomy: an initial experience. Surg Endosc 13 (1999) 1015-1020
58. Tatum R.P., Wong J.A., Figueredo E.J., et al. Return of esophageal function after treatment for achalasia as determined by impedance-manometry. J Gastrointest Surg 11 (2007) 1403-1409
59. Zaninotto G., Costantini M., Portale G., et al. Etiology, diagnosis, and treatment of failures after laparoscopic Heller myotomy for achalasia. Ann Surg 235 (2002) 186-192
60. Malthaner R.A., Tood T.R., Miller L., et al. Long-term results in surgically managed esophageal achalasia. Ann Thorac Surg 58 (1994) 1343-1346 [discussion: 1346-7]
61. Ellis Jr. F.H., Watkins Jr. E., Gibb S.P., et al. Ten to 20-year clinical results after short esophagomyotomy without an antireflux procedure (modified Heller operation) for esophageal achalasia. Eur J Cardiothorac Surg 6 (1992) 86-89 [discussion: 90]
62. Bonatti H., Hinder R.A., Klocker J., et al. Long-term results of laparoscopic Heller myotomy with partial fundoplication for the treatment of achalasia. Am J Surg 190 (2005) 874-878
63. Jeansonne L.O., White B.C., Pilger K.E., et al. Ten-year follow-up of laparoscopic Heller myotomy for achalasia shows durability. Surg Endosc 21 (2007) 1498-1502
64. Lopushinsky S.R., and Urbach D.R. Pneumatic dilatation and surgical myotomy for achalasia. JAMA 296 (2006) 2227-2233
65. Kostic S., Kjellin A., Ruth M., et al. Pneumatic dilatation or laparoscopic cardiomyotomy in the management of newly diagnosed idiopathic achalasia: results of a randomized controlled trial. World J Surg 31 (2007) 470-478
66. Imperiale T.F., O'Connor J.B., Vaezi M.F., et al. A cost-minimization analysis of alternative treatment strategies for achalasia. Am J Gastroenterol 95 (2000) 2737-2745
67. Patti M.G., Feo C.V., Diener U., et al. Laparoscopic Heller myotomy relieves dysphagia in achalasia when the esophagus is dilated. Surg Endosc 13 (1999) 843-847
68. Miller D.L., Allen M.S., Trastek V.F., et al. Esophageal resection for recurrent achalasia. Ann Thorac Surg 60 4 (1995) 922-925
69. Devaney E.J., Lannettoni M.D., Orringer M.B., et al. Esophagectomy for achalasia: patient selection and clinical experience. Ann Thorac Surg 72 (2001) 854-858
70. Banbury M.K., Rice T.W., Goldblum J.R., et al. Esophagectomy with gastric reconstruction for achalasia. J Thorac Cardiovasc Surg 117 6 (2000) 1077-1084
71. Sandler R.S., Nyren O., Ekbom A., et al. The risk of esophageal cancer in patients with achalasia: a population-based study. JAMA 274 (1995) 1359-1362
72. Dunaway P.M., and Wong R.K. Risk and surveillance intervals for squamous cell carcinoma in achalasia. Gastrointest Endosc Clin N Am 11 (2001) 425-434
73. Zendehdel K., Nyren O., Edberg A., et al. Risk of esophageal adenocarcinoma in achalasia patients, a retrospective cohort study in Sweden. Am J Gastroenterol 102 (2007) 1-5
74. Brucher B.L., Stein H.J., Bartels H., et al. Achalasia and esophageal cancer: incidence, prevalence, and prognosis. World J Surg 25 (2001) 745-749
75. Hirano I., and Kahrilas P.J. Esophageal disorders. In: Spiller T., and Grundy D. (Eds). Pathophysiology of the enteric nervous system (2004), Blackwell Publishing, Oxford (UK) 105-125